71058 Federal Register / Vol. 69, No. 235 / Wednesday, December 8, 2004 / Notices 

Trans # Acquiring Acquired Entities 

20050117 ......................... Estate of Ernest L. Samuel ............... Mr. Charles E. Pompea ..................... Primac Corp., Primary Steel, Inc., 

Primtech LLC 

TRANSACTIONS GRANTED EARLY TERMINATION—11/04/2004

20050020 ......................... PacifiCare Health Systems, Inc ........ American Medical Security Group, 

Inc.

American Medical Security Group, 

Inc. 

20050039 ......................... J. W. Childs Equity Partners, III, L.P Vestar Capital Partners, III, L.P ........ Sheridan Holdings, Inc. 

20050069 ......................... AFFC Holdings, Inc ........................... BP p.l.c .............................................. Amoco Fabrics and Fibers Company, 

BP Corporation North America Inc. 

20050087 ......................... ViroPharma Incorporated .................. Eli Lilly and Company ....................... Eli Lilly and Company. 

TRANSACTIONS GRANTED EARLY TERMINATION—11/05/2004

20050073 ......................... Worley Group Limited ....................... Parsons Employee Stock Ownership 

Plan.

Parsons E&C Corporation 

20050104 ......................... Raul Alarcon, Jr ................................. Sumner M. Redstone ........................ Infinity Broadcasting Corporation of 

San Francisco 

20050105 ......................... CompuCredit Corporation ................. Dennis M. Mathisen .......................... BANKFIRST.

20050114 ......................... Atlantic Power Corporation ............... Teton Power Holdings, LLC .............. Onondaga Cogeneration Limited 

Partnership, Split Rock Holdings, 

LLC, Topsham Hydroelectric Generating Facility. 

20050115 ......................... Atlantic Power Corporation ............... ArcLight Energy Partners Fund II, 

L.P.

Umatilla Power Funding, LLC 

20050122 ......................... Cypress Merchant Banking Partners 

II L.P.

Stone Canyon Entertainment Corp ... Stone Canyon Entertainment Corp. 

20050129 ......................... Ryerson Tull, Inc ............................... Alcoa Inc ............................................ Integris Metals, Inc. 

TRANSACTIONS GRANTED EARLY TERMINATION—11/08/2004

20050113 ......................... Southern Wine & Spirits of America, 

Inc.

David Taub ........................................ Darmart Enterprises, Inc., Gallo 

Wines Distributors, L.L.C. d/b/a, 

Premier Wines & Spirit, New York 

Depot Distributing Co., LLC. 

20050125 ......................... United Online, Inc .............................. Classmates Online, Inc ..................... Classmates Online, Inc. 

20050126 ......................... Warburg Pincus Private Equity VIII, 

L.P.

Avicis, Inc .......................................... Avicis, Inc. 

20050127 ......................... World Directories S.a.r.l. (‘‘WDS’’) .... VNU N.V ............................................ VNU World Directories Inc. 

20050128 ......................... Ryerson Tull, Inc ............................... BHP Billiton Pic ................................. Integris Metals, Inc. 

20050130 ......................... Rush Enterprises, Inc ........................ Jesse and Milo Kirk ........................... American Truck Source, Inc. 

20050131 ......................... J.P. Morgan Chase & Co .................. Michael Hirtenstein ............................ WestCom Corporation 

20050133 ......................... Centene Corporation ......................... Swope Community Enterprises ......... FirstGuard Health Plan, Inc., 

FirstGuard, Inc. 

20050134 ......................... Auto Sueco, Lda ................................ Aktiebolaget Volvo ............................. SABA Holding Company. 

20050135 ......................... CharterMac ........................................ Capri Realty Capital, LLC ................. Capri Capital Limited Partnership 

20050138 ......................... KeyCorp ............................................. American Express Company ............. American Express Business Finance 

Corporation 

TRANSACTIONS GRANTED EARLY TERMINATION—11/09/2004

20050066 ......................... Armor Holdings, Inc ........................... The Specialty Group, Inc .................. The Specialty Group, Inc. 

20050120 ......................... Fuji Photo Film Co., Ltd .................... Arch Chemicals, Inc .......................... Arch Chemical Specialties Products, 

Inc., Arch Electronic Chemicals, 

Inc., Arch Specialty Chemicals, 

Inc. 

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay, Contact Representative, 

or Renee Hallman, Case Management 

Assistant, Federal Trade Commission, 

Premerger Notification Office, Bureau of 

Competition, Room H–303, Washington, 

DC 20580, (202) 326–3100.

By direction of the Commission. 

Donald S. Clark, 

Secretary.

[FR Doc. 04–26938 Filed 12–7–04; 8:45 am] 

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–05–0138] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 498–1210 or send an 

email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Human 

Resources and Housing Branch, New 

Executive Office Building, Room 10235, 

Washington, DC 20503 or by fax to (202) 

395–6974. Written comments should be 

received within 30 days of this notice. 

Federal Register / Vol. 69, No. 235 / Wednesday, December 8, 2004 / Notices 71059

Proposed Project 

Pulmonary Function Testing Course 

Approval Program, 29 CFR 1910.1043, 

OMB No. 0920–0138—Revision—

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC). 

NIOSH has the responsibility under 

the Cotton Dust Standard, 29 CFR 

1920.1043, for approving courses to 

train technicians to perform pulmonary 

function testing in the Cotton Dust 

Industry. Successful completion of a 

NIOSH-approved course is mandatory 

under the Standard. To carry out its 

responsibility, NIOSH maintains a 

Pulmonary Function Testing Course 

Approval Program. The program 

consists of an application submitted by 

potential sponsors who seek NIOSH 

approval to conduct courses. The 

application form and added materials, 

including an agenda, vitae, and course 

materials are reviewed by NIOSH to 

determine if the applicant has 

developed a program which adheres to 

the criteria required in the Standard. 

Following approval, any subsequent 

changes to the course are submitted by 

course sponsors via letter or e-mail and 

reviewed by NIOSH staff to assure that 

the changes in faculty or course content 

continue to meet course requirements. 

Course sponsors also voluntarily 

submit an annual report to inform 

NIOSH of their class activity level and 

if any faculty changes have occurred. 

Applications and materials to be a 

course sponsor and carry out training 

are submitted voluntarily by institutions 

and organizations throughout the 

country. This is required by NIOSH to 

evaluate a course to determine whether 

it meets the criteria in the Standard and 

whether technicians will be adequately 

trained as mandated under the 

Standard. One question regarding 

faculty changes was added to the 

previously approved annual report. 

There will be no cost to respondents 

except their time to participate. The 

estimated annualized burden is 64 

hours.

ANNUALIZED BURDEN TABLE

Respondents Number of

respondents 

Number of

responses/

respondents 

Average

burden/

response

(in hrs) 

Initial Application .......................................................................................................................... 5 1 3.5 

Annual Report .............................................................................................................................. 50 1 45/60 

Report for Course Changes ........................................................................................................ 12 1 45/60 

Dated: November 29, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–26913 Filed 12–7–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[7Day–05–AN] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call the CDC Reports 

Clearance Officer at (404) 498–1210. 

CDC is requesting an emergency 

clearance for this data collection with a 

seven-day public comment period. CDC 

is requesting OMB approval of this 

package seven days after the end of the 

public comment period. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. As this is an emergency 

clearance, please direct comments to the 

CDC Desk Officer, Human Resources 

and Housing Branch, New Executive 

Office Building, Room 10235, 

Washington, DC 20503 or by fax to (202) 

395–6974. Comments should be 

received within seven days of this 

notice. 

Proposed Project: Performance 

Evaluation Program for Severe Acute 

Respiratory Syndrome Antibody (SARS 

Ab) Testing—New—Public Health 

Practice Program Office (PHPPO), 

Centers for Disease Control and 

Prevention (CDC). 

Great attention has been focused on 

SARS which is a viral respiratory illness 

caused by a coronavirus, called SARSassociated coronavirus (SARS–CoV). 

SARS was first reported in Asia in 

February 2003. Over the next few 

months, the illness spread to more than 

two dozen countries in North America, 

South America, Europe, and Asia before 

the SARS global outbreak of 2003 was 

contained.

The SARS virus has recently been 

shown to be endemic in some 

populations, and as the season most 

conducive for SARS infection 

approaches, the possibility for an 

outbreak or epidemic exists. Therefore, 

it is imperative that the CDC ensure all 

State Public Health laboratories and 

other laboratories designated by CDC 

remain proficient in performing SARS 

testing. For this reason, it is of critical 

public health importance, at this time, 

that the CDC develop and maintain a 

performance evaluation program for 

SARS. 

CDC, through the Model Performance 

Evaluation Program (MPEP), intends to 

provide a new SARS–CoV testing 

performance evaluation program (SARS 

MPEP). This program will offer external 

performance evaluation for SARS Ab 

testing. Participation in the performance 

evaluation program is expected to lead 

to improved SARS testing performance 

because participants have the 

opportunity to identify areas for 

improvement. This will help ensure 

accurate testing as a basis for 

development of SARS prevention and 

intervention strategies. 

This external quality assessment 

program will be made available at no 

cost (for receipt of sample panels) to 54 

state laboratories. Participants in the